Brixadi 58284-0264
Generic: Buprenorphine
Product NDC
58284-0264- Manufacturer
- Braeburn Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- June 6, 2023
- Listing Expires
- December 31, 2027
- Application
- NDA210136
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine | 64 mg/.18mL |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Packaging Options(1)
1 SYRINGE, GLASS in 1 CARTON (58284-264-01) / .18 mL in 1 SYRINGE, GLASS